You are here: Industry Insights > CDMO

News List

Fujifilm Diosynth Biotechnologies announce successful completion of its 100th paveway europeanpharmaceuticalreview
July 03, 2017
Fujifilm Diosynth Biotechnologies has announced the successful completion of its 100th program using its pAVEway™ Advanced Protein Expression system…
Juniper Pharma Services brings PSD-1 spray dryer online cphi-online
June 27, 2017
The addition enables the CDMO to scale-up early-phase bench top processes to support later stage clinical development and niche, low volume manufacturing requirements.
CoreRx, Aimmune Unveil Joint Expansion contractpharma
June 14, 2017
Together will advance treatment of peanut and other food allergies
Rentschler Biotechnologie and Rentschler Fill Solutions Announce Strategic Partnership for One-Stop b3cnewswire
June 13, 2017
Rentschler Biotechnologie GmbH today announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the needs of Rentschler Biotechnologie’s clients.
CE Mark for Implandata's EYEMATE™ System for Improved Monitoring and Management of Glaucoma Patients b3cnewswire
June 01, 2017
apceth Biopharma GmbH, a cell therapy company with a proprietary portfolio of genetically modified mesenchymal stem cell therapeutics for the treatment of inflammatory diseases and cancer.
Thermo Fisher Scientific to acquire Patheon cphi-online
May 25, 2017
Patheon provides entry into the attractive, high-growth CDMO market.
CDMO invests in system to boost pharmaceutical formulation development cphi-online
March 07, 2017
Alcami will use the D8 DISCOVER HTS to add XRD capabilities to their laboratory service portfolio.
Quotient Clinical announces second US acquisition: QS Pharma pharmaasia
March 06, 2017
Quotient Clinical announced acquisition of QS Pharma, the contract development and manufacturing organisation from Charles River Laboratories International
Amatsigroup Acquires Disposable-Lab contractpharma
January 22, 2017
Enhances capabilities in development services for injectable drug products

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page